(fifthQuint)Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction.

 Subjects will be enrolled at 3 investigative sites.

 At Visit 1, a medical, headache, and medication history will be collected and a physical and neurological exam with vital signs will be performed.

 An ECG will be completed if one has not been completed in the previous 6 months.

 Subjects will be administered a series of psychological tests to help the study doctor decide whether or not a subject is eligible.

 The Headache Impact Test-6 and Migraine Specific Quality of Life Questionnaire will be completed at each visit.

 During a 30-day Baseline Period, subjects will treat with their usual medication and complete a daily Diary documenting headache symptoms and treatment.

 At Visits 2 and 3 subjects will complete the Mental Efficiency Workload Test and Migraine Early Warning Tool.

 Following randomization at Visit 2, subjects will treat daily for 30 days with Treximet or a matching placebo.

 Subjects will be provided with Treximet for rescue of any persisting or recurring headache.

 During the Treatment Period, subjects will complete a daily Diary reporting headache symptoms and response to treatment.

 After the 30-day Treatment Period, subjects will exit the study at Visit 3 .

.

 Treximet for Prevention of Post Traumatic Headache Associated With Cognitive Dysfunction@highlight

This study will evaluate the effectiveness of Treximet when taken for post traumatic headache by measuring any change in the number of headache days or any change in a subject's ability to think following treatment with study medication.

 Eligible subjects will complete 3 visits.

 Following Visit 1, subjects will treat with their usual medication and document headache symptoms and therapy in a Headache Diary.

 After 30 days, subjects will return for Visit 2 and be randomized (like the flip of a coin) to receive Treximet or matching placebo to treat at the same time each day.

 Treximet will be provided to treat any headache that occurs.

 Subjects will complete a daily Diary.

 After 30 days, subjects will exit the study at Visit 3.

